SYSTEMATIC REVIEW
Published on 13 Feb 2025
Evaluating the efficacy and safety of immune checkpoint inhibitors in first and second-line treatments for recurrent and metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis of RCTs with a focus on PD-L1 expression
doi 10.3389/fimmu.2025.1508885
- 158 views